UPDATE : Monday, September 7, 2020
상단여백
‘Tagrisso’s benefit as 1st-line treatment overrides resistance risk’
Will AstraZeneca’s targeted therapy Tagrisso (ingredient: osimertinib) soli...
by Park Gi-taek  |  2019-01-17 12:34
라인
GenBody releases rapid influenza diagnostic kit
GenBody said on Monday it has started to sell a rapid diagnostic test kit f...
by Park Gi-taek  |  2018-12-17 14:33
라인
Shinpoong’s drug becomes first-line malaria treatment in Côte d'Ivoire
Korean drugmaker Shinpoong Pharm said Côte d'Ivoire listed the co...
by Park Gi-taek  |  2018-12-17 14:20
라인
Can AI-using medical technologies get coverage?
“Most of the medical technologies that use artificial intelligence (AI) are...
by Park Gi-taek  |  2018-12-06 13:04
라인
Bukwang completes phase-2b test on new diabetes drug
Bukwang Pharmaceutical said Thursday it has completed administering MLR-102...
by Park Gi-taek  |  2018-11-29 15:19
라인
‘Patients may try to sell their medical information’
“Patients may try to sell their medical information (unless physicians and ...
by Park Gi-taek  |  2018-11-26 16:21
라인
‘JAK inhibitors to change quality of life for people with polycythemia vera’
“Janus kinase (JAK) inhibitors, a type of medication that suppresses the ac...
by Park Gi-taek  |  2018-11-09 13:32
라인
Acer submits new drug application for rare disease to FDA
Acer Therapeutics, a NASDAQ-listed pharmaceutical firm in which Bukwang Pha...
by Park Gi-taek  |  2018-10-31 15:55
라인
Korea’s healthcare exports up 30 pct. in H1
South Korea’s exports of products in the healthcare sector surged 30.9 perc...
by Park Gi-taek  |  2018-10-19 11:46
라인
‘Radon causes lung cancer; some sanitary pads might be harmful’
“Academics have already proved that radon is one of the causes of lung canc...
by Park Gi-taek  |  2018-10-18 16:02
라인
Medtronic’s subcontractor worker aided surgery at NMC
The latest controversy over a medical device salesman’s illegal surgery ass...
by Park Gi-taek  |  2018-10-05 15:10
라인
Hanmi’s new diabetes drug to take on Lilly’s in tests
Sanofi said it would begin global phase-3 clinical trials to compare Hanmi ...
by Park Gi-taek  |  2018-09-28 11:32
라인
‘High-value medical devices marketable without sufficient clinical grounds’
The government is seeking to allow companies to sell potentially valuable m...
by Park Gi-taek  |  2018-09-06 15:58
라인
‘We know Korean genes best’
A Korean authority in genetic medicine established a genetic testing compan...
by Park Gi-taek  |  2018-07-24 14:42
라인
Orders for original drugs spike amid ban of Chinese valsartan
With the government’s ban on the import and sale of generic drugs containin...
by Park Gi-taek  |  2018-07-10 16:03
라인
Edwards Lifesciences leads heart valves market
A heart surgeon needs lots of tools such as heart valve replacement, tissue...
by Park Gi-taek  |  2018-06-26 15:53
라인
NHIS head slams health ministry’s incompetence
The head of the state-run company managing national health insurance in Kor...
by Park Gi-taek  |  2018-06-22 15:43
라인
Will 3 N. Korean doctors visit Seoul this year?
North Korean physicians might participate in an upcoming international acad...
by Park Gi-taek  |  2018-06-18 15:20
라인
Lipiodol excluded from shortage prevention drugs
The Korean health authorities have excluded Guerbet Korea’s Lipiodol from “...
by Park Gi-taek  |  2018-06-11 11:30
라인
‘Bone formation best to prevent osteoporotic fractures’
Osteoporosis is rapidly growing in South Korea. The number of patients suff...
by Park Gi-taek  |  2018-06-07 16:06
-1234567-
176 civic groups furious over government-doctors deal176 civic groups furious over government-doctors deal
여백
Most viewed
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top